WARSAW, Ind.--(BUSINESS WIRE)--Biomet, Inc. announced today that in conjunction with its Fiscal 2013 Fourth Quarter and Year End release, you are invited to participate in the conference call on Thursday, July 11, 2013 at 4:30 p.m. Eastern.
Individuals wishing to participate in the conference call may dial (877) 606-1415. International callers should dial (760) 666-3758. The conference ID number is 10622937.
Biomet, Inc. and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. Biomet’s product portfolio encompasses large joint reconstructive products, including orthopedic joint replacement devices, and bone cements and accessories; sports medicine, extremities and trauma products, including internal and external orthopedic fixation devices; spine and bone healing products, including spine hardware, spinal stimulation devices, and orthobiologics, as well as electrical bone growth stimulators; dental reconstructive products; and other products, including microfixation products and autologous therapies. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in approximately 90 countries.